Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.
about
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphomaPhase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and TargetsPrimary cutaneous lymphomas: diagnosis and treatmentOral retinoids and rexinoids in cutaneous T-cell lymphomasCutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementProteomic Approaches to Biomarker Discovery in Cutaneous T-Cell LymphomaExtracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma.Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T-cell lymphoma.Erythroderma: review of a potentially life-threatening dermatosis.Immunopathogenesis and therapy of cutaneous T cell lymphoma.Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomasInterleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.Diagnosis, staging, and monitoring of cutaneous T-cell lymphoma.Treatment planning in cutaneous T-cell lymphoma.Erythroderma/exfoliative dermatitis: a synopsis.Clinicopathological spectrum of mycosis fungoides.Cutaneous T-cell lymphoma: epidemiology, etiology, and classification.Emerging drugs in cutaneous T-cell lymphomas.Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force ofThe new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.Mycosis Fungoides: Tumour d'emblee.On the diagnosis of erythrodermic cutaneous T-cell lymphoma.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Lymphoproliferative lesions of the skin.Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndromeCutaneous malignant lymphomas: update 2006.Mycosis fungoides: a dermatological masquerader.Mycosis fungoides--a review of the management of 28 patients and of the recent literature.The diagnosis, staging, and treatment options for mycosis fungoides.Development of a plaque infiltrated with large CD30+ T cells over a silicone-containing device in a patient with history of Sézary syndromeMycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and updateErythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.Erythrodermic mycosis fungoides with hypereosinophilic syndrome: a rare presentationTriads in dermatology
P2860
Q24626963-8DD4AB1E-25BE-4FC9-9715-E64B6A7FC69AQ24681480-5017C3C6-6487-43C2-B871-5A0052316FB8Q26746551-3EE7BF2A-6B86-406B-BA2D-96609C5775FFQ26772207-25010A58-691B-435F-B718-BD72192FECE6Q26992062-4DBA9127-1641-4B89-9A8D-BEBBFA42439CQ27024076-32A8D9C7-A1B9-4878-9987-121DFE6F3DCBQ28071331-EAB604C8-E27E-471C-BD50-FBC17547F40BQ30650570-753F5CA0-18A1-4F06-8570-B824A957B475Q33375694-03343281-8E71-4229-A0C6-2971EE7C495BQ33400756-4BB74136-DF6C-4E89-9815-C4428B88094FQ33567844-72D8B020-CEF6-43F6-9152-13C2AA1D22F4Q33726963-154B2407-360E-48C6-97D1-CB9FE6721AE8Q34516083-C2D626CB-5D54-4EBB-94D9-F0A8DD6232E6Q35022833-3EDB56CB-7BB9-4725-A1B7-EC23FC3759A3Q35083893-AFD68820-22CE-4D16-A617-B04FE7979E42Q35584244-9C5CB5E7-57A0-4C5B-99C3-C0D514A2E203Q35612009-2B4397CF-4C75-49C9-84C5-632A812314B3Q35612011-9C4CB908-2522-4148-9F50-B30CD8C61636Q35615038-766A236D-0D4B-4D51-A02D-EA3EEF9768EFQ35804408-D3B46275-2892-4A0E-9352-EDAB34085AF1Q35808394-FA9D3BAC-6C9A-4BF1-B424-890BF68F52F6Q36150634-69200222-D137-43F4-819A-51C1C1F1BBCFQ36174236-1D928D84-9703-4CF5-BF08-96E3D6743136Q36286422-5243924C-9EE9-4513-B562-40AF016B9085Q36315227-D87C217A-69E7-47AE-AAE9-199DCAECB1E9Q36349486-657F7C91-76F7-44D2-8453-75CC37E2F6ECQ36367915-96B9EF37-448D-456D-9BE9-44921A48E538Q36470196-7FA91CB2-8884-46B1-AB4A-CD79DBDE9B03Q36549255-68901275-3870-45FB-9C12-50810B8685E5Q36620714-E2173CAF-C96A-4E99-A972-F1722B31527FQ36626781-36A1DCCB-63FE-4549-B82F-CCCD57B8B4D9Q36642858-EDD643AC-DF42-4A0E-87B0-75211BA3AE6BQ36697655-1990348D-66B2-4535-B211-09EAD10B9C23Q36703890-7488E391-E503-4705-87F8-CE9A0C9AB4CDQ36771218-E118F306-E98D-4A08-805E-44FACA436232Q36865775-5231A19B-22DA-4E29-B468-CC348E4CE509Q36977648-85E8870F-1443-451C-BB71-8611D0351A6AQ36995610-4338D70F-EE6C-49BA-8FA1-3900C640ACE0Q37081647-F4C05BAC-60DE-4833-BDCF-09A2DAC7D31FQ37187038-1FB2DE9E-FBB1-4546-B797-BEE8FBE18A1A
P2860
Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@ast
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@en
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@nl
type
label
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@ast
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@en
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@nl
prefLabel
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@ast
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@en
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@nl
P2093
P356
P1476
Update on erythrodermic cutane ...... ciety for Cutaneous Lymphomas.
@en
P2093
Elise Olsen
Eric C Vonderheid
Günter Burg
Liliane Laroche
Madeleine Duvic
Maria Grazia Bernengo
Mark Pittelkow
Masahiro Takigawa
Peter Heald
P304
P356
10.1067/MJD.2002.118538
P407
P577
2002-01-01T00:00:00Z